Patents by Inventor Russell P. BOWLER

Russell P. BOWLER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10684292
    Abstract: Disclosed are methods of identifying, predicting and treating subjects at risk for exacerbation or the presence of a respiratory disease, by detecting expression levels of one or more proteins associated with the respiratory disease.
    Type: Grant
    Filed: March 13, 2018
    Date of Patent: June 16, 2020
    Assignee: National Jewish Health
    Inventor: Russell P. Bowler
  • Publication number: 20180299469
    Abstract: Disclosed are methods of identifying, predicting and treating subjects at risk for exacerbation or the presence of a respiratory disease, by detecting expression levels of one or more proteins associated with the respiratory disease.
    Type: Application
    Filed: March 13, 2018
    Publication date: October 18, 2018
    Inventor: Russell P. BOWLER
  • Patent number: 9952225
    Abstract: Disclosed are methods of identifying, predicting and treating subjects at risk for exacerbation or the presence of a respiratory disease, by detecting expression levels of one or more proteins associated with the respiratory disease, wherein said one or more proteins is selected from the group of CCL24, IL2RA, APOA4, GC, IgA, LPA, KLK3 F, FAS, NRCAM, TNFRSFIOC, IL12B, IL23A, RAGE, CCL20, ICAM1, SERPINA7, CDH13 and CDH1, and wherein said respiratory disease may be chronic obstructive pulmonary disease or emphysema.
    Type: Grant
    Filed: January 23, 2015
    Date of Patent: April 24, 2018
    Assignee: National Jewish Health
    Inventor: Russell P. Bowler
  • Publication number: 20170003300
    Abstract: Disclosed are methods of identifying, predicting and treating subjects at risk for exacerbation or the presence of a respiratory disease, by detecting expression levels of one or more proteins associated with the respiratory disease, wherein said one or more proteins is selected from the group of CCL24, IL2RA, APOA4, GC, IgA, LPA, KLK3 F, FAS, NRCAM, TNFRSFIOC, IL12B, IL23A, RAGE, CCL20, ICAM1, SERPINA7, CDH13 and CDH1, and wherein said respiratory disease may be chronic obstructive pulmonary disease or emphysema.
    Type: Application
    Filed: January 23, 2015
    Publication date: January 5, 2017
    Inventor: Russell P. BOWLER